ARENA PHARMACEUTICALS INC (ARNA)
Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 224.57M | 219.50M | 243.30M | 161.00M | 158.80M | |||
| Marketable Securities | 325.90M | 884.50M | 496.30M | 284.60M | 88.20M | |||
| Receivables | N/A | N/A | 1.70M | 5.10M | 14.40M | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 19.00M | 35.30M | 18.70M | 10.00M | 19.80M | |||
| Total Current Assets | 569.47M | 1.14B | 759.90M | 460.70M | 281.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 28.23M | 32.90M | 36.90M | 23.10M | 30.10M | |||
| Investments And Advances | 160.80M | N/A | 370.90M | 82.40M | 24.20M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 26.22M | 18.50M | 6.30M | 120.70M | 3.60M | |||
| Total Non-Current Assets | 215.24M | 51.40M | 414.20M | 226.20M | 58.00M | |||
| TOTAL ASSETS | 784.71M | 1.19B | 1.17B | 686.90M | 339.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.05M | 4.40M | 3.80M | 3.30M | 4.00M | |||
| Accrued Expenses | 47.96M | 41.70M | 35.10M | 20.40M | 38.00M | |||
| Accounts Payable | 13.30M | 12.00M | 6.00M | 6.20M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 28.70M | |||
| Total Current Liabilities | 66.32M | 58.10M | 45.00M | 29.90M | 72.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 36.16M | 41.20M | 45.60M | 49.40M | 57.70M | |||
| Other Non-Current Liabilities | 8.99M | 11.00M | 12.10M | 1.30M | 2.10M | |||
| Total Non-Current Liabilities | 45.15M | 52.20M | 57.70M | 50.70M | 59.80M | |||
| TOTAL LIABILITIES | 111.47M | 110.30M | 102.70M | 80.60M | 132.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.12B | -1.51B | -1.10B | -1.50B | -1.49B | |||
| Additional Paid In Capital | 2.80B | 2.59B | 2.17B | 2.11B | 1.70B | |||
| Minority Interest | N/A | N/A | 0.00 | 0.00 | 1.30M | |||
| Common Shares | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -280.00K | 700.00K | 1.30M | -200.00K | -1.20M | |||
| Shares Outstanding | 61.56M | 58.60M | 50.20M | 49.40M | 39.30M | |||
| Tangible Book Value per Share | 10.94 | 18.44 | 21.34 | 12.27 | 5.27 | |||
| Total Shareholders' Equity | 673.24M | 1.08B | 1.07B | 606.30M | 207.10M | |||
| TOTAL LIABILITIES AND EQUITY | 784.71M | 1.19B | 1.17B | 686.90M | 339.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.04 | 0.04 | 0.08 | 0.28 | |||
| Current Ratio | 8.59 | 19.61 | 16.89 | 15.41 | 3.89 | |||
| Return On Assets (ROA) | -78.56% | -33.99% | 33.86% | -4.28% | -26.94% | |||
| Return On Equity (ROE) | -91.56% | -37.45% | 37.11% | -4.85% | -44.13% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 34.79% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 100.86% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 100.86% | N/A | N/A | |||
All data in USD